On February 6, 2025, the FDA provided updates on the safety and effectiveness of breast implants. BISA provides a brief summary and why this info is crucial for the public.

Every woman is at risk for breast cancer. You never know when you or someone you love will be faced with decisions about breast implants. We want to keep you safe, healthy and informed with information you can trust. KNOWLEDGE IS BEAUTIFUL

As we welcome 2025, we remain committed to transparency, patient safety, and empowering women with the information they deserve. Take a peek at the links we want to start highlighting in 2025.

While breast implants have long been promoted as safe and effective, Breast Implant Safety Alliance (BISA) was published in an article that shines a light on the safety concerns and asks an important question: Are breast implants really as safe as we think? 

Are breast implants as safe as we think, and why do we still question the safety? Members of the Breast Implant Safety Alliance (BISA) reviewed a new article examining the reputation of the FDA concerning the safety of breast implants.

Jennifer Cook began as a breast implant patient. She learned about the risk of developing cancer from breast implants at a school play. A few months later, she started experiencing symptoms and was diagnosed with a cancer called BIA-ALCL. In this video, she shares her experience as a patient and as an advocate.

Save the date for the 10th International Breast Surgery Workshop (IBSW) and the 6th World Consensus Conference on BIA-ALCL, scheduled for April 11-12, 2025, in Tampa, Florida,

BISA wants to keep women healthy, safe, and informed. How much do YOU really know about breast implants? Test you knowledge by taking our short quiz.

BISA wants to keep women healthy, safe, and informed. Here are 5 important things all women should know about breast implants.

In a recent podcast episode, author Mel Robbins shared her breast implant story. Many of BISA’s members can relate to her story. Can you?

Breast Implant Associated Lymphoma (BIA-ALCL) is a type of non-Hodgkin's lymphoma, a cancer of the immune system. Accumulating evidence suggests that BIA-ALCL may be a common—not rare—risk from exposure to Allergan Biocell® breast implants.